This proposal seeks to continue and expand our studies with fluoranthene (FA) by utilizing a modification of a (32P)- postlabeling assay to detect and quantify DNA adducts in mice and human lymphoblast cell lines for eventual application as a dosimeter to monitor DNA damage in tissues from occupationally or environmentally exposed human populations. Experimental protocols for the animal and human cell studies will parallel those in use in the respective Core Laboratories in which FA has been demonstrated to be tumorigenic and mutagenic, respectively. DNA will be prepared from mouse lung, liver, thymus/spleen and leukocytes, target organs and cells for PAC in this assay, and from kidney for a non-target organ source of control DNA. Adduct formation and repair will be studied as a function of tumorigenic activity, time post-treatment, and dose levels extending downward to exposures reflecting ambient environmental levels or to the minimum level for adduct detection. Experiments with metabolically competent and incompetent human lymphoblast cell lines will be similarly performed to correlate with mutagenic activity and to examine effects of FA concentration and time post-treatment. Red blood cells and sera from the mouse experiments will also be prepared for Project C-1 investigators for protein adduct measurements. DNA from mouse tissues and leukocytes and from human cells will also be isolated for Project C-3 investigators for mutational spectra analysis. In addition to the initial experimental with FA, iterative studies will be performed for other compounds (benzo(a)pyrene, cyclopenta(c,d)pyrene, 6-nitochrysene) and an effluent extract from the combustion of pulverized coal.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Program Projects (P01)
Project #
5P01ES001640-12
Application #
3897885
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Tomita-Mitchell, Aoy; Ling, Losee Lucy; Glover, Curtis L et al. (2003) The mutational spectrum of the HPRT gene from human T cells in vivo shares a significant concordant set of hot spots with MNNG-treated human cells. Cancer Res 63:5793-8
Tomita-Mitchell, A; Kat, A G; Marcelino, L A et al. (2000) Mismatch repair deficient human cells: spontaneous and MNNG-induced mutational spectra in the HPRT gene. Mutat Res 450:125-38
Durant, J L; Lafleur, A L; Busby Jr, W F et al. (1999) Mutagenicity of C24H14 PAH in human cells expressing CYP1A1. Mutat Res 446:1-14
Wang, J S; He, X; Mulder, P P et al. (1999) Comparative tumorigenicity of the cyclopenta-fused polycyclic aromatic hydrocarbons aceanthrylene, dihydroaceanthrylene and acephenanthrylene in preweanling CD-1 and BLU:Ha mouse bioassays. Carcinogenesis 20:1137-41
Busby Jr, W F; Smith, H; Crespi, C L et al. (1997) Mutagenicity of the atmospheric transformation products 2-nitrofluoranthene and 2-nitrodibenzopyranone in Salmonella and human cell forward mutation assays. Mutat Res 389:261-70
Busby Jr, W F; Smith, H; Plummer, E F et al. (1997) Mutagenicity of cyclopenta-fused polynuclear aromatic hydrocarbons and a non-polar fraction from a fuel combustion sample in a Salmonella forward mutation assay without exogenous metabolic activation. Mutat Res 391:117-25
Durant, J L; Busby Jr, W F; Lafleur, A L et al. (1996) Human cell mutagenicity of oxygenated, nitrated and unsubstituted polycyclic aromatic hydrocarbons associated with urban aerosols. Mutat Res 371:123-57
Palotas, A B; Rainey, L C; Feldermann, C J et al. (1996) Soot morphology: an application of image analysis in high-resolution transmission electron microscopy. Microsc Res Tech 33:266-78
Wang, J S; Busby Jr, W F (1996) Bacterial and human cell mutagenicity and mouse lung tumorigenicity of the oxygenated polynuclear aromatic hydrocarbon phenalenone. Fundam Appl Toxicol 33:212-9
Wang, J S; Busby, W F; Wogan, G N (1995) Tissue distribution of DNA adducts in pre-weanling BLU:Ha mice treated with a tumorigenic dose of fluoranthene. Cancer Lett 92:9-19

Showing the most recent 10 out of 65 publications